disulfiram has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies
Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, T | 1 |
| Kephart, J | 1 |
| Bronson, E | 1 |
| Anand, M | 1 |
| Daly, C | 1 |
| Spasojevic, I | 1 |
| Bakthavatsalam, S | 1 |
| Franz, K | 1 |
| Berg, H | 1 |
| Karachaliou, GS | 1 |
| James, OG | 1 |
| Howard, L | 1 |
| Halabi, S | 1 |
| Harrison, MR | 1 |
| Armstrong, AJ | 1 |
| George, DJ | 1 |
1 trial available for disulfiram and Prostatic Neoplasms, Castration-Resistant
| Article | Year |
|---|---|
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Topics: Copper; Disulfiram; Humans; Male; Peritoneal Neoplasms; Prospective Studies; Prostatic Neoplasms, Ca | 2022 |